In developing our science and progressing our pipeline, our approach is to establish strategic collaborations with leading biopharmaceutical companies who are commercializing innovative anti-cancer therapeutics.

To date, we are pleased to have worked with the following collaborators and partners.


Our strong links with world leaders are reinforced via our Scientific Advisory board.